Jump to content

Cineromycin B

From Wikipedia, the free encyclopedia
Cineromycin B
Names
IUPAC name
(3Z,5R,6Z,8S,9Z,13S,14R)-5,8-dihydroxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one[1]
Identifiers
3D model (JSmol)
  • InChI=1S/C17H26O4/c1-12-6-5-7-13(2)15(18)8-10-17(4,20)11-9-16(19)21-14(12)3/h7-12,14-15,18,20H,5-6H2,1-4H3/b10-8-,11-9-,13-7-/t12-,14+,15-,17+/m0/s1
    Key: RLNOIXQIRICASI-HTNMZXOESA-N
  • C[C@H]1CC/C=C(\[C@H](/C=C\[C@@](/C=C\C(=O)O[C@@H]1C)(C)O)O)/C
Properties
C17H26O4
Molar mass 294.391 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Cineromycin B is an antiadipogenic antibiotic with the molecular formula C17H26O4 which is produced by the bacterium Streptomyces cinerochromogenes.[1][2][3][4]

References

[edit]
  1. ^ a b "Cineromycin B". Pubchem.ncbi.NLM.nih.gov.
  2. ^ Matsuo, Hirotaka; Kondo, Yoshiyuki; Kawasaki, Takashi; Imamura, Nobutaka (August 2015). "Cineromycin B isolated from Streptomyces cinerochromogenes inhibits adipocyte differentiation of 3T3-L1 cells via Krüppel-like factors 2 and 3". Life Sciences. 135: 35–42. doi:10.1016/j.lfs.2015.05.020. PMID 26092481.
  3. ^ Rai, Amit K.; Singh, Sudhir P.; Pandey, Ashok; Larroche, Christian; Soccol, Carlos Ricardo (30 November 2021). Current Developments in Biotechnology and Bioengineering: Technologies for Production of Nutraceuticals and Functional Food Products. Elsevier. p. 359. ISBN 978-0-12-823643-7.
  4. ^ Parte, Aidan; Whitman, William B.; Goodfellow, Michael; Kämpfer, Peter; Busse, Hans-Jürgen; Trujillo, Martha E.; Ludwig, Wolfgang; Suzuki, Ken-ichiro (23 June 2012). Bergey's Manual of Systematic Bacteriology: Volume 5: The Actinobacteria. Springer Science & Business Media. p. 1607. ISBN 978-0-387-68233-4.

Further reading

[edit]
  • Weinstein, M. J.; Wagman, G. H. (1 April 2000). Chromatography of Antibiotics. Elsevier. p. 120. ISBN 978-0-08-085829-6.